From April 1, 2023 to June 30, 2023, the company has repurchased 388,092 shares, representing 26.94% for KRW 10,425.88 million. With this, the company has completed the repurchase of 598,487 shares, representing 29.77% for KRW 14,994.85 million under the buyback announced on February 13, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19,600 KRW | -0.56% | -1.21% | -17.12% |
1st Jan change | Capi. | |
---|---|---|
-17.12% | 102M | |
+21.98% | 43.92B | |
+24.56% | 23.09B | |
+19.25% | 15.35B | |
+14.03% | 13.61B | |
+46.40% | 12.02B | |
-10.14% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.6B |
- Stock Market
- Equities
- A003120 Stock
- News Ilsung Is Co., Ltd.
- Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 13, 2023.